Register entry

Cephalon, Inc.

Registered sites
0
Drug products
23
Live patents
38
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Exclusivity

Patents

38

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
FENTORAFENTANYL CITRATEJun 2028
TREANDABENDAMUSTINE HYDROCHLORIDEMar 2029
TREANDABENDAMUSTINE HYDROCHLORIDESept 2029
TREANDABENDAMUSTINE HYDROCHLORIDESept 2029
TREANDABENDAMUSTINE HYDROCHLORIDEMar 2030
TREANDABENDAMUSTINE HYDROCHLORIDEOct 2030
TREANDABENDAMUSTINE HYDROCHLORIDEApr 2031
Catalogue

Marketed products

23

Showing 23 of 23.

BrandGeneric nameFormCategory
AMRIXCyclobenzaprine HydrochlorideCAPSULE, EXTENDED RELEASENDA
AMRIXCyclobenzaprine HydrochlorideCAPSULE, EXTENDED RELEASENDA
GRANIXtbo-filgrastimINJECTION, SOLUTIONBLA
GRANIXtbo-filgrastimINJECTION, SOLUTIONBLA
GRANIXtbo-filgrastimINJECTION, SOLUTIONBLA
GRANIXtbo-filgrastimINJECTION, SOLUTIONBLA
HERZUMATRASTUZUMABINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONBLA
HERZUMATRASTUZUMABKITBLA
-ModafinilTABLETDRUG FOR FURTHER PROCESSING
NuvigilArmodafinilTABLETNDA
ProvigilModafinilTABLETNDA
TREANDABendamustine HydrochlorideINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
TREANDABendamustine HydrochlorideINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
-Tiagabine HydrochlorideTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-Tiagabine HydrochlorideTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-Tiagabine HydrochlorideTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-Tiagabine hydrochlorideTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
TrisenoxArsenic TrioxideINJECTION, SOLUTIONNDA
Truximarituximab-abbsINJECTION, SOLUTIONBLA
Truximarituximab-abbsINJECTION, SOLUTIONBLA
-armodafinilTABLETDRUG FOR FURTHER PROCESSING
-armodafinilTABLETDRUG FOR FURTHER PROCESSING
-armodafinilTABLETDRUG FOR FURTHER PROCESSING
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.